In this study, we hypothesize that TM4SF5-targeting Ex (miR-143) can effectively deliver MACC1-suppressing miRNA to CRC cells, resulting in enhanced anti-tumor effects [15]. The gene discussed is MACC1; the disease is neoplasm.